Xiaoyan Yang

Xiaoyan Yang

Auto-generated profile, based on publicly available information

Xiaoyan Yang

Department of Neurology Key Laboratory of Brain Function and Brain Disease Prevention and Treatment of Guizhou Province (ZSYS(2025)030), Affiliated Hospital of Zunyi Medical University Zunyi Guizhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Epilepsia
Verified
Journal Article
Closed access
YXYong Xu
Yong Xu
LWLin Wan
Lin Wan
WHWen He
Wen He
YWYang‐Yang Wang
Yang‐Yang Wang
QWQiu‐Hong Wang
Qiu‐Hong Wang
LZLi-Ping Zou
Li-Ping Zou

28 December 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
ZZZunlin Zhou
Zunlin Zhou
XWXiujuan Wang
Xiujuan Wang
JYJuan Yang
Juan Yang
JQJiyao Qin
Jiyao Qin
BFBidan Feng
Bidan Feng
QZQing Hai Zhang
Qing Hai Zhang
Background: Epilepsy is a prevalent chronic neurological disorder characterized by its complex pathophysiology, with microglial phagocytosis being crucial for synaptic remodeling and epileptogenesis. Transglutaminase‐2 (TGM2) holds a critical role in regulating microglial function and cognitive synaptic plasticity; however, the precise mechanisms by which TGM2 influences synaptic pruning and epileptogenesis remain unclear. Aim: This study aims to investigate the role of TGM2 in seizure susceptibility and its regulatory effects on microglial‐mediated synaptic phagocytosis in a chronic epilepsy model. Accordingly, the following objectives were set: elucidate the fluorescent localization and protein expression characteristics of TGM2 in normal and epileptic brain tissues; analyze the impact of TGM2 on epileptic behavioral phenotypes; and investigate the molecular mechanisms underlying its regulation of microglial activation and synaptic phagocytic function using an epileptic mouse model. Methods: In vivo experiments were performed using a kainic acid (KA)–induced chronic epilepsy mouse model established via intrahippocampal injection. Western blot and immunofluorescence analyses were employed to examine TGM2 expression and localization in the hippocampus of KA‐treated mice. Adeno‐associated virus vectors were used to achieve TGM2 overexpression or knockdown in the hippocampus, after which video‐monitored behavioral assays and in vivo field potential recordings were used to evaluate seizure latency, frequency, and severity. Golgi–Cox staining, western blotting, and immunofluorescence were used to assess dendritic spine density in the hippocampal CA1 region, microglial polarization (M1/M2 phenotypes), and phagocytic activity. In vitro studies in BV2 microglia explored the molecular mechanisms of action of TGM2 using ubiquitination assays targeting ATP‐binding cassette transporter A1 (ABCA1). Results: TGM2 expression was significantly upregulated in the hippocampus of KA‐induced epileptic mice, which prolonged the latency period to spontaneous recurrent seizures (SRS) and reduced SRS frequency. In contrast, TGM2 knockdown exacerbated seizure severity, which was characterized by a shortened latency period and increased SRS frequency. Golgi–Cox staining revealed that TGM2 overexpression decreased dendritic spine density in the CA1 region, whereas TGM2 knockdown had the opposite effect, indicating a role in synaptic remodeling. Functional analyses showed that TGM2 promoted microglial polarization toward an anti‐inflammatory M2 phenotype, enhanced phagocytic activity, and upregulated the components of the complement system as well as the phagocytosis‐related proteins. Conversely, TGM2 deficiency promoted the pro‐inflammatory M1 phenotype, reduced phagocytic capacity, and downregulated the components of the complement system and the phagocytosis‐related proteins. Mechanistically, TGM2 overexpression increased ABCA1 protein stability by inhibiting its ubiquitination, whereas TGM2 knockdown promoted ABCA1 ubiquitination and degradation. Immunofluorescence analysis revealed enhanced colocalization of TGM2 within the microglia. Conclusion: This study revealed that TGM2 suppresses epileptogenesis by enhancing microglial synaptic phagocytosis through the inhibition of ABCA1 ubiquitination, thereby regulating synaptic remodeling in the hippocampus. These findings establish a critical molecular link between TGM2‐mediated microglial function and epileptogenesis, providing novel insights into therapeutic strategies targeting neuroinflammation and synaptic plasticity in epilepsy.

1 January 2025 in Behavioural Neurology
Verified
Journal Article
Open access
JCJunting Chen
Junting Chen
CLCai Li
Cai Li
LCLing Chen
Ling Chen
ZZZiyi Zhao
Ziyi Zhao
YZYongsu Zheng
Yongsu Zheng
RDRenli Deng
Renli Deng
Background: Sleep disorders, such as insomnia, are pervasive and frequently comorbid with depression, significantly affecting the quality of life of patients. Insomnia is characterized by difficulty initiating or maintaining sleep, which leads to impairment. Depression is characterized by persistent sadness and loss of interest, and it often features symptoms of insomnia. Understanding their interaction will be done for treatment strategies concerning both disorders. Despite the existence of extensive studies on insomnia and depression, there is a significant gap in bibliometric analysis specifically addressing the comorbidity of these two conditions. Objectives: This study is aimed at conducting a bibliometric analysis of research in insomnia comorbid with depression (ICD) to identify research trends, collaboration patterns, influential works, and hotspots. Methods: The study involved performance analysis to evaluate research productivity and trends, science mapping to visualize the intellectual structure and thematic evolution of the field, and network analysis to examine research collaboration and knowledge structure. Tools such as VOSviewer, CiteSpace, and GraphPad Prism were utilized for data analysis. Results: A total of 1624 publications on the comorbidity of insomnia and depression from 2000 to 2024 were included, encompassing both articles and reviews. Publication volume showed a steady growth from 2000 to 2008, followed by a significant increase from 2019 onward. The United States was the most productive country, followed by China. Key authors such as Allison G. Harvey, Charles M. Morin, and Daniel J. Buysse have made substantial contributions to the field. Major influential journals included Sleep Medicine , Journal of Affective Disorders , and Frontiers in Psychiatry . Research trends identified included the exploration of neurobiological mechanisms, cognitive behavioral therapy for insomnia (CBT‐i), and personalized treatment approaches. Conclusion: This bibliometric analysis provides valuable insights into the evolving landscape of research on ICD. Future research should focus on personalized, multimodal interventions, expanding the application of CBT‐i, exploring neurobiological mechanisms, and improving patients’ quality of life through integrated treatment strategies.

11 January 2023 in Ibrain
Verified
Journal Article
Open access
XYXiaoyan Yang
Xiaoyan Yang
WLWenbo Lv
Wenbo Lv
YYYong Yang
Yong Yang
JYJuan Yang
Juan Yang
QZQing Hai Zhang
Qing Hai Zhang
ZXZucai Xu
Zucai Xu
It was found the expression of progesterone receptor membrane component 2 (PGRMC2) in the histone of epileptic mice was lower than that of normal mice. In this study, we found by the immunofluorescence technique, PGRMC2 was expressed in both astrocytes and neurons of the mouse hippocampus. In addition, the seizure latency and seizure grade of mice in each group were observed after stereotactic injection of the PGRMC2 knockdown virus, PGRMC2 overexpression lentivirus, and related null virus into the hippocampus of mice. It was found that the seizure latency of mice in the PTZ + siPGRMC2 group was prolonged compared with the null virus group. The seizure latency was shortened in the PTZ + PGRMC2 group. The number of grade IV and above seizures in the PTZ + siPGRMC2 group was significantly reduced, while the number of grade IV and above seizures in the PTZ + PGRMC2 group was significantly increased. It was found that the nerve cells in the PTZ + siPGRMC2 group were still intact. In the PTZ + PGRMC2 group, the neural cells were damaged, the intercellular space was widened, and the number of cells was reduced. These findings support that PGRMC2 may be involved in epileptic seizures.

14 August 2023 in Ibrain
Verified
Journal Article
Open access
JQJi‐Yao Qin
Ji‐Yao Qin
ZZZun‐Lin Zhou
Zun‐Lin Zhou
YZYuan‐Qing Zhou
Yuan‐Qing Zhou
YCYa Chen
Ya Chen
XYXiao‐Yan Yang
Xiao‐Yan Yang
ZXZucai Xu
Zucai Xu
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by selective degeneration of upper and lower motor neurons. Although dyskinesia is the most prominent clinical manifestation of ALS, with an in‐depth understanding of disease pathogenesis and clinical detection, more and more ALS patients are found to have nonmotor symptoms, such as sensory impairment. Genetic testing technology has developed rapidly in recent years. New genes have been proven to be involved in the pathogenesis of ALS. However, according to the existing research evidence, no literature has reported that patients with ALS have leucine‐rich repeats and sterility α mutations in motif 1 (LRSAM1) and receptor expression accessory protein 1 (REEP1). The mutation sites of REEP1 gene have not been reported, and the simultaneous mutations of two genes have not been reported. In the largest human gene mutation frequency database gnomad, the mutation sites of two genes are currently defined as new heterozygous variants with unclear clinical significance. Therefore, this article reports the clinical data of this case to further deepen the clinicians' understanding of the disease, and may provide evidence for further study of the new genotype–phenotype of LRSAM1 and REEP1.

20 March 2023 in Ibrain
Verified
Journal Article
Open access
XYXiao‐Yan Yang
Xiao‐Yan Yang
YZYong‐Su Zheng
Yong‐Su Zheng
JTJin‐Mei Tuo
Jin‐Mei Tuo
HZHai‐Qing Zhang
Hai‐Qing Zhang
ZXZucai Xu
Zucai Xu
A 48‐year‐old female patient was hospitalized for 5 days after a cold. Encephalitis was considered after preliminary history and routine examination, but the patient did not show significant improvement after antiviral treatment. At this time, magnetic resonance imaging indicated pituitary atrophy, and the patient's medical history was assessed. She had a history of postpartum bleeding and amenorrhea 15 years ago. The supplementary examination indicated hormonal abnormalities. These suggested that the patient may have had Sheehan's syndrome (SS). After hormone supplementation treatment for 10 days, her condition improved. This case suggested that in female patients with neuropsychiatric disorders with a history of previous postpartum hemorrhage, attention needs to be paid to screening for SS to improve the related diagnosis and treatment rate.